Leveraging a Humanized SLE Mouse Model to Evaluate Next-Generation Immune-Cell-Targeted Therapeutics (Download)

Facebook
LinkedIn
Fill out the form below to download this content.
Leveraging-a-Humanized-SLE-Mouse-Model-to-Evaluate-Next-Generation-Immune-Cell-Targeted-Therapeutics

Leveraging a Humanized SLE Mouse Model to Evaluate Next-Generation Immune-Cell-Targeted Therapeutics

Name(Required)
By clicking submit you consent to receive email communications about products and services of Medicilon and are in accordance with our Privacy Policy. You may opt out at any time.

Search Medicilon

Preclinical CRO

Medicilon Congratulates Livzon Pharmaceutical on the Approval of LiYouBao® — China’s Only Export-Qualified r-FSH Injection Meeting Global International Standards

Preclinical CRO

Medicilon Boston R&D Center Awarded Full AAALAC International Accreditation, Further Elevating Global Service Capabilities

Preclinical CRO

RACI Congress 2026

Contact Medicilon

Name(Required)
Address(Required)